237 related articles for article (PubMed ID: 31372832)
41. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
42. Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation.
Li DY; Chen WJ; Luo L; Wang YK; Shang J; Zhang Y; Chen G; Li SK
Int J Mol Med; 2017 Dec; 40(6):1895-1906. PubMed ID: 29039552
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of miRNAs in enterovirus 71-infected cells.
Xun M; Ma CF; Du QL; Ji YH; Xu JR
Virol J; 2015 Apr; 12():56. PubMed ID: 25889836
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
45. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
47. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
48. Identification of featured biomarkers in breast cancer with microRNA microarray.
Zhang M; Liu D; Li W; Wu X; Gao C; Li X
Arch Gynecol Obstet; 2016 Nov; 294(5):1047-1053. PubMed ID: 27365106
[TBL] [Abstract][Full Text] [Related]
49. Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer.
Zellinger B; Bodenhofer U; Engländer IA; Kronberger C; Strasser P; Grambozov B; Fastner G; Stana M; Reitsamer R; Sotlar K; Sedlmayer F; Zehentmayr F
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33255991
[TBL] [Abstract][Full Text] [Related]
50. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
51. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
Jayavelu ND; Bar N
BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
[TBL] [Abstract][Full Text] [Related]
52. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
54. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
55. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
56. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
57. Computational Identification of microRNA-17-3p in Breast Cancer Cells.
Shincy JS; Panagal M; Jereena J; Vengatagiri GY; Vittalrao KR; Sivakumar P; Gopinath V; Kumar KM; Sekar D
Microrna; 2017 Dec; 6(3):208-212. PubMed ID: 28875846
[TBL] [Abstract][Full Text] [Related]
58. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
59. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G
Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617
[TBL] [Abstract][Full Text] [Related]
60. Regulation of Heat Shock Proteins by miRNAs in human breast cancer.
Ozgur A; Tutar L; Tutar Y
Microrna; 2014; 3(2):118-35. PubMed ID: 25541910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]